EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome

Chung-Hsin Wu iD, Xun-Sheng Pan, Li-Yu Su, Shieh-Yueh Yang

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241813771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Chung-Hsin Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, National Taiwan Normal University, Taipei 106, Taiwan. Hauptthemen laut MEDLINE: Neurofilament Proteins, Biomarkers, Cognitive Dysfunction, Dog Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TTY BIOPHARM CO., LTD., SHIUN CHAO BIOPHARM CO., LTD., National Taiwan Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The number of elderly dogs is increasing significantly worldwide, and many elderly dogs develop canine cognitive dysfunction syndrome (CCDS). CCDS is the canine analog of Alzheimer’s disease (AD) in humans. It is very important to develop techniques for detecting CDDS in dogs. Thus, we used the detection of neurofilament light chains (NfL) in plasma as a blood-based biomarker for the early diagnosis of canine Alzheimer’s disease using immunomagnetic reduction (IMR) technology by immobilizing NfL antibodies on magnetic nanoparticles. According to the 50-point CCDS rating scale, we divided 36 dogs into 15 with CCDS and 21 without the disease. The results of our IMR assay showed that the plasma NfL levels of dogs with CCDS were significantly increased compared to normal dogs (p < 0.01). By plasma biochemical analysis, we further confirmed that the liver and renal dysfunction biomarkers of dogs with CCDS were significantly elevated compared to normal dogs (p < 0.01–0.05). On the basis of our preliminary study, we propose that IMR technology could be an ideal biosensor for detecting plasma NfL for the early diagnosis of CCDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofilament ProteinsBiomarkersCognitive DysfunctionDog DiseasesAnimalsDogsEarly DiagnosisMaleFemaleAlzheimer Disease

Stichwörter der Autor:innen

caninecognitive dysfunctionimmunomagnetic reductionneurofilament light chain

Substanzen

Neurofilament ProteinsBiomarkersneurofilament protein L

Autor:innen und Institutionen

  • School of Life Science, National Taiwan Normal University, Taipei 106, Taiwan.
  • Zaixing Animal Hospital, Taipei 116, Taiwan.
  • Department of Physiology, College of Medicine, National Taiwan University, Taipei 106, Taiwan.
  • MagQu Co., Ltd., New Taipei City 112, Taiwan.

ORCID-Profile: Chung-Hsin Wu

Förderung

  • TTY BIOPHARM CO., LTD.
  • SHIUN CHAO BIOPHARM CO., LTD.
  • National Taiwan Normal University

Zitieren

APA

Wu, C. H., Pan, X. S., Su, L. Y., & Yang, S. Y. (2023). Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813771

Vancouver

Wu CH, Pan XS, Su LY, Yang SY. Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813771

BibTeX
@article{Wu2023,
  author = {Wu, Chung-Hsin and Pan, Xun-Sheng and Su, Li-Yu and Yang, Shieh-Yueh},
  title = {Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241813771}
}
Kostenlos starten →